HIGHLIGHTS
- who: Gloria Ursino from the University of Geneva, Geneva, Switzerland have published the paper: Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis, in the Journal: NATURE COMMUNICATIONS NATURE COMMUNICATIONS
- what: The authors show pre-clinical and observational clinical data indicating that recombinant S100A9 is a putative investigational drug displaying safety and efficacy profiles owning therapeutic potential. To further evaluate the translational significance of the findings , the authors performed an observational clinical study aimed at gathering plasmatic S100A9 content in patients with decompensated diabetes and healthy controls. As indicated in Fig 7K and based . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.